Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
CN Stock MarketDetailed Quotes
Bloomage Biotechnology Corporation Limited (688363)
- 41.35
- -2.00-4.61%
Market Closed Apr 30 15:00 CST
19.92BMarket Cap78.17P/E (TTM)
42.08High41.22Low5.19MlotVolume42.00Open43.35Prev Close215.41MTurnover1.08%Turnover Ratio68.23P/E (Static)481.68MShares61.8552wk High2.79P/B19.92BFloat Cap40.1052wk Low52.02Limit Up481.68MShs Float312.99Historical High34.68Limit Down1.98%Range %40.10Historical Low0.11Dividend TTM41.50Avg Price2.93MlotAsk0.27%Div Yield TTM1Lot Size2.08MlotBid
Bloomage Biotechnology Corporation Limited (688363) Cash Flow
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -23.98%887.51M | -21.00%4.43B | -16.69%3.35B | -15.09%2.41B | -12.05%1.17B | -13.60%5.61B | -9.28%4.03B | -11.11%2.84B | -4.63%1.33B | -3.32%6.49B |
| Refunds of taxes and levies | 39.25%15.05M | -36.20%28.08M | -40.59%24.99M | -4.34%15.83M | -20.02%10.81M | -34.11%44.02M | -2.70%42.05M | -46.03%16.55M | -32.19%13.52M | -40.78%66.8M |
| Cash received relating to other operating activities | 55.49%43.55M | 3.68%241.72M | -3.52%107.75M | -3.53%67.4M | -29.05%28.01M | -11.39%233.14M | -44.00%111.68M | -57.09%69.87M | -64.98%39.48M | 13.57%263.11M |
| Cash inflows from operating activities | -21.57%946.11M | -20.13%4.7B | -16.57%3.49B | -14.75%2.5B | -12.62%1.21B | -13.71%5.89B | -10.70%4.18B | -13.64%2.93B | -9.45%1.38B | -3.36%6.82B |
| Goods services cash paid | -60.82%132.66M | -27.82%1.07B | -21.62%847.7M | -17.48%597.23M | -4.05%338.57M | -4.76%1.48B | -1.06%1.08B | -8.40%723.77M | -10.70%352.87M | -14.95%1.56B |
| Staff behalf paid | -43.78%215.3M | -8.82%1.16B | -5.93%915.89M | -2.24%660.27M | 15.41%382.97M | 2.42%1.27B | 1.04%973.59M | -1.45%675.39M | -26.06%331.85M | 17.22%1.24B |
| All taxes paid | 22.77%74.74M | -51.53%254.13M | -50.89%202M | -43.02%161.98M | -52.03%60.88M | -15.07%524.29M | -1.44%411.29M | 1.55%284.28M | -4.39%126.92M | -30.13%617.34M |
| Cash paid relating to other operating activities | -12.17%392.46M | -22.15%1.59B | -15.74%1.21B | -12.42%857.96M | -16.32%446.82M | -24.47%2.05B | -27.02%1.44B | -32.35%979.63M | -28.44%533.97M | 2.14%2.71B |
| Cash outflows from operating activities | -33.69%815.15M | -23.45%4.07B | -18.63%3.18B | -14.48%2.28B | -8.65%1.23B | -13.07%5.32B | -12.15%3.91B | -16.87%2.66B | -21.90%1.35B | -4.70%6.12B |
| Net cash flows from operating activities | 669.96%130.96M | 11.15%627.45M | 12.66%308.76M | -17.49%218.33M | -165.93%-22.98M | -19.32%564.51M | 16.67%274.06M | 41.95%264.62M | 117.57%34.85M | 10.15%699.65M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | --128.97K | --128.97K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received from returns on investments | 19.18%1.01M | -68.21%10.42M | -79.03%6.8M | -96.96%946.44K | -88.18%843.82K | 137.93%32.79M | 318.38%32.44M | 396.57%31.13M | 50.69%7.14M | -57.71%13.78M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --4.47K | 885.28%2.07M | 969.22%2.25M | --1.74M | ---- | 210,393.38%210.49K | 210,393.38%210.49K | ---- | ---- | -99.99%100 |
| Cash received relating to other investing activities | 1,288.19%416.46M | -30.08%451M | -46.18%331M | -84.07%90M | -91.04%30M | -64.02%645M | -57.95%615M | -57.60%565M | -67.86%335M | -48.44%1.79B |
| Cash inflows from investing activities | 1,253.48%417.47M | -31.62%463.63M | -47.47%340.18M | -84.45%92.68M | -90.98%30.84M | -62.47%678M | -55.95%647.65M | -55.47%596.13M | -67.33%342.14M | -48.55%1.81B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 6.01%101.52M | -54.85%325.68M | -61.41%225.47M | -66.95%151.15M | -58.07%95.76M | -29.98%721.39M | -22.80%584.27M | -19.02%457.34M | -24.43%228.37M | 47.95%1.03B |
| Cash paid to acquire investments | 124.63%13.5M | -76.09%68.85M | -84.22%42.53M | -95.95%10.91M | -95.33%6.01M | 63.43%287.98M | 140.57%269.48M | 150.06%269.37M | --128.7M | 42.90%176.21M |
| Cash paid relating to other investing activities | --446.46M | 156.89%333.96M | 143.96%243.96M | -14.29%60M | ---- | -89.28%130M | -89.80%100M | -91.76%70M | -94.03%40.01M | -64.04%1.21B |
| Cash outflows from investing activities | 451.69%561.48M | -36.06%728.49M | -46.32%511.96M | -72.13%222.06M | -74.37%101.77M | -52.90%1.14B | -48.41%953.74M | -47.67%796.71M | -59.16%397.08M | -44.34%2.42B |
| Net cash flows from investing activities | -103.03%-144.01M | 42.59%-264.87M | 43.88%-171.77M | 35.50%-129.37M | -29.09%-70.93M | 24.72%-461.37M | 19.15%-306.09M | -9.17%-200.57M | -173.28%-54.94M | 26.71%-612.88M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | --2.52M | --2.52M | --2.52M | ---- | ---- | ---- | ---- | ---- | -35.51%57.71M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | --2.52M | --2.52M | --2.52M | ---- | ---- | ---- | ---- | ---- | 13.41%6M |
| Cash from borrowing | -43.72%66.67M | 107.00%310.28M | 117.46%217.46M | --167.46M | --118.46M | --149.9M | --100M | ---- | ---- | ---- |
| Cash inflows from financing activities | -43.72%66.67M | 108.68%312.8M | 119.98%219.98M | --169.98M | --118.46M | 159.72%149.9M | 93.36%100M | ---- | ---- | -74.61%57.71M |
| Borrowing repayment | -58.99%24.08M | 77.46%202.63M | 77.70%202.21M | 69.53%178.13M | -43.91%58.71M | 7.35%114.18M | 7.38%113.8M | -0.36%105.07M | 198.53%104.69M | 189.70%106.36M |
| Dividend interest payment | 104.96%1.32M | -69.84%56.08M | -70.32%54.99M | -59.20%1.31M | -50.92%641.66K | -39.14%185.93M | -39.10%185.28M | -98.91%3.22M | -22.28%1.31M | 25.78%305.48M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | ---- | ---- | ---- | --1.91M | --1.91M | ---- | ---- |
| Cash payments relating to other financing activities | -30.67%6.63M | -64.82%56.39M | -66.25%50.84M | -74.54%36.45M | -91.63%9.56M | -7.57%160.3M | 172.17%150.62M | 311.01%143.17M | 567.95%114.21M | 47.10%173.43M |
| Cash outflows from financing activities | -53.54%32.02M | -31.56%315.1M | -31.50%308.04M | -14.15%215.89M | -68.70%68.91M | -21.33%460.41M | -3.40%449.7M | -42.46%251.47M | 308.94%220.21M | 47.25%585.28M |
| Net cash flows from financing activities | -30.07%34.65M | 99.26%-2.3M | 74.82%-88.06M | 81.74%-45.91M | 122.50%49.55M | 41.14%-310.52M | 15.50%-349.7M | 34.74%-251.47M | -1,472.53%-220.21M | -210.05%-527.57M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -258.61%-8.48M | -48.81%4M | 216.65%11.03M | 714.43%12.79M | 449.65%5.34M | -26.06%7.81M | -51.63%3.48M | -114.50%-2.08M | -426.58%-1.53M | -64.25%10.56M |
| Net increase in cash and cash equivalents | 133.62%13.12M | 282.54%364.28M | 115.85%59.95M | 129.47%55.84M | 83.87%-39.02M | 53.61%-199.57M | 31.27%-378.25M | 48.54%-189.5M | -76.66%-241.83M | -25.93%-430.24M |
| Add:Begin period cash and cash equivalents | 59.38%977.78M | -24.55%613.49M | -24.55%613.49M | -24.55%613.49M | -24.55%613.49M | -34.60%813.06M | -34.60%813.06M | -34.60%813.06M | -34.60%813.06M | -21.56%1.24B |
| End period cash equivalent | 72.49%990.89M | 59.38%977.78M | 54.88%673.44M | 7.34%669.33M | 0.57%574.48M | -24.55%613.49M | -37.25%434.81M | -28.74%623.56M | -48.37%571.23M | -34.60%813.06M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | -- | -- | -- | -- | PwC China (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm